CM Hospitalar S/A Past Earnings Performance
Past criteria checks 5/6
CM Hospitalar S/A has been growing earnings at an average annual rate of 12.9%, while the Healthcare industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 27.7% per year. CM Hospitalar S/A's return on equity is 9.9%, and it has net margins of 2.9%.
Key information
12.9%
Earnings growth rate
7.3%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 27.7% |
| Return on equity | 9.9% |
| Net Margin | 2.9% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
CM Hospitalar S/A (BVMF:VVEO3) Not Doing Enough For Some Investors As Its Shares Slump 49%
May 11
CM Hospitalar S/A (BVMF:VVEO3) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Analysts Are Updating Their CM Hospitalar S/A (BVMF:VVEO3) Estimates After Its Annual Results
Mar 29Why Investors Shouldn't Be Surprised By CM Hospitalar S/A's (BVMF:VVEO3) 28% Share Price Plunge
Mar 27Here's Why CM Hospitalar S/A (BVMF:VVEO3) Has A Meaningful Debt Burden
Jan 15Here's What To Make Of CM Hospitalar S/A's (BVMF:VVEO3) Decelerating Rates Of Return
Dec 14CM Hospitalar S/A (BVMF:VVEO3) Has More To Do To Multiply In Value Going Forward
Jun 07Returns On Capital Signal Tricky Times Ahead For CM Hospitalar S/A (BVMF:VVEO3)
Jan 16Be Wary Of CM Hospitalar S/A (BVMF:VVEO3) And Its Returns On Capital
Aug 31Statutory Earnings May Not Be The Best Way To Understand CM Hospitalar S/A's (BVMF:VVEO3) True Position
May 17Pinning Down CM Hospitalar S/A's (BVMF:VVEO3) P/E Is Difficult Right Now
Dec 09Revenue & Expenses Breakdown
How CM Hospitalar S/A makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 11,242 | 326 | 1,171 | 0 |
| 31 Dec 23 | 11,084 | 360 | 1,133 | 0 |
| 30 Sep 23 | 10,805 | 162 | 1,091 | 0 |
| 30 Jun 23 | 10,234 | 209 | 1,072 | 0 |
| 31 Mar 23 | 9,647 | 200 | 985 | 0 |
| 31 Dec 22 | 8,747 | 260 | 869 | 0 |
| 30 Sep 22 | 7,741 | 278 | 761 | 0 |
| 30 Jun 22 | 6,963 | 286 | 764 | 0 |
| 31 Mar 22 | 6,634 | 458 | 732 | 0 |
| 31 Dec 21 | 6,219 | 395 | 673 | 0 |
| 30 Sep 21 | 6,031 | 372 | 656 | 0 |
| 30 Jun 21 | 5,746 | 337 | 519 | 0 |
| 31 Mar 21 | 5,055 | 136 | 458 | 0 |
| 31 Dec 20 | 4,413 | 122 | 423 | 0 |
| 31 Dec 19 | 3,003 | 36 | 317 | 0 |
| 31 Dec 18 | 2,641 | 34 | 248 | 0 |
| 31 Dec 17 | 1,696 | 59 | 117 | 0 |
| 31 Dec 16 | 1,148 | 165 | 84 | 0 |
| 31 Dec 15 | 998 | -1 | 79 | 0 |
| 31 Dec 14 | 866 | 3 | 57 | 0 |
| 31 Dec 13 | 720 | 3 | 63 | 0 |
Quality Earnings: VVEO3 has high quality earnings.
Growing Profit Margin: VVEO3's current net profit margins (2.9%) are higher than last year (2.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VVEO3's earnings have grown by 12.9% per year over the past 5 years.
Accelerating Growth: VVEO3's earnings growth over the past year (63.3%) exceeds its 5-year average (12.9% per year).
Earnings vs Industry: VVEO3 earnings growth over the past year (63.3%) exceeded the Healthcare industry 63.3%.
Return on Equity
High ROE: VVEO3's Return on Equity (9.9%) is considered low.